Tulmimetostat
Tulmimetostat (CPI-0209) is an oral EZH1/EZH2 inhibitor with demonstrated antitumor activity. It is utilized in preclinical research for ovarian cancer and advanced solid tumors, showing efficacy in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
2567686-02-4
Product Name Alternative
CPI-0209, CPI0209, CPI 0209, Histone Methyltransferase, HistoneMethyltransferase, EZH2, EZH1, Tulmimetostat
Field of Research
Epigenetics & Chromatin
Purity
97.30% (May vary between batches)
Solubility
DMSO:140 mg/mL (249.06 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.56 mM)
Smiles
CC1=C2C (O[C@@] (C) (O2) [C@@]3 (CC[C@H] (CC3) N4CC (OC) C4) [H]) =C (Cl) C=C1C (NCC5=C (SC) C=C (C) NC5=O) =O
Molecular Formula
C28H36ClN3O5S
Molecular Weight
562.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-89886AF594 0.1 mL
Rabbit Monoclonal Osteoactivin/GPNMB Antibody (105) [Alexa Fluor 594]
Sign In for Pricing
View Details